TPX2 and pancreatic neoplasm: Moreover, increased expression of IGFBP-3 upon treatment with TPX2 siRNA was observed in three pancreatic cancer cell lines such as KLM1, KP4, and Panc1 by Western blot analysis (Fig.5A) and real-time RT-PCR (Fig.5B).